Readify

Los Angeles Times Report on Goto’s UCLA Liver Transplant

Tokyo Vice

The Los Angeles Times Report on Goto’s UCLA Liver Transplant made a hidden arrangement between a Japanese organized-crime leader and a major American medical center a public controversy. By connecting Tadamasa Goto’s treatment at UCLA to the FBI’s effort to obtain intelligence on the Yamaguchi-gumi, the reporting raised questions about organ scarcity, international law enforcement, and the movement of potentially criminal funds—while leaving important questions about what the hospital knew unresolved.

The transplant and the intelligence bargain

In January or February 2001, doctors at Showa University told Tadamasa Goto that he would die without a liver transplant soon. He had hepatitis C and a heart condition, and was considered a very unlikely transplant candidate in Japan. In April, he approached the FBI through Hoshi Hitoshi, a former fixer with deep connections to the Liberal Democratic Party. The FBI wanted information about organized crime figures and networks in Japan, which the National Police Agency had declined to share on privacy grounds.

Goto offered a comprehensive list of Yamaguchi-gumi members, affiliated front companies and financial institutions, as well as information about North Korean activity. In return, he sought a U.S. visa so he could receive a transplant at UCLA. The FBI pressed U.S. Immigration and Customs to grant the visa; UCLA, not the FBI, performed the surgery. The transplant took place on July 5. According to the account, Goto supplied only a fraction of the information he had promised, then returned to Japan and did not speak with the FBI again. The reporting therefore described not a transplant arranged by federal agents, but access to treatment secured through a deal in which the FBI helped open the door.

The account also conveyed the substantial uncertainty around the arrangement. Goto told an associate he had paid $3 million for the liver. Police reports instead put the figure at $1 million and speculated that his doctor received $100,000 for each visit to Japan, usually at the Imperial Hotel. The FBI agreement was known only to Goto’s inner circle. Reviewing other Yamaguchi-gumi materials, the narrator also came to suspect that three other people with Japanese organized-crime ties had received liver transplants at UCLA.

Reporting and publication

The report emerged after the narrator had assembled information from a U.S. Justice Department source and sources in Japanese police and the underworld. He first tried to place the story in Japan. A weekly magazine rejected it outright, and no publisher would take the article when he was ready to publish. Editors objected that the story was old, worried that it would anger the National Police Agency, or doubted that the FBI would confirm it. One newspaper showed interest but wanted to focus its attack on the FBI, a framing the narrator did not consider useful.

The narrator sent a copy to the Yomiuri, which ignored it, as did the other Japanese newspapers. He had already begun speaking with the Los Angeles Times before the Washington Post article was ready. He worked for weeks with San Francisco bureau chief John Glionna and Charles Ornstein. The Washington Post article did not mention UCLA; the narrator’s account says that omission pleased the Los Angeles Times collaborators. The Post story appeared on its front page on May 31. These were related but distinct publication efforts: the Washington Post piece did not include the UCLA element, while Japanese coverage of the transplant story later identified the Los Angeles Times as its source.

Once the story was public, Japanese outlets could no longer ignore it, although some did. Most of the outlets that covered it attributed the information to the Los Angeles Times rather than independently verifying the report or investigating further. The narrator regarded this as a way for domestic media to report troubling news while distancing themselves from it. The story thus circulated widely enough to become visible, but its passage through the press did not produce the same degree of independent scrutiny.

Organ scarcity and unresolved accountability

The reporting placed Goto’s case against Japan’s stringent transplant system, where donors were scarce and operations rare. People in Japan who needed organs often had to leave the country or die waiting. From the American perspective, the narrator questioned why Japanese criminals might receive transplants ahead of law-abiding U.S. patients. The controversy therefore brought together two different issues: the medical need of individual patients and the fairness of access to a limited supply of organs across national borders.

UCLA and Dr. Busuttil said they did not make moral judgments about patients and treated them according to medical need. It had not been proved that either UCLA or Dr. Busuttil knew, at the time of the transplants, that any of the four Japanese patients had organized-crime ties. They did not explicitly deny knowing of those ties, instead declining to address what they knew and when. An investigation by the U.S. Centers for Medicare and Medicaid Services together with UCLA found no evidence of improper conduct, according to the Los Angeles Times. That finding addressed whether improper conduct had occurred; it did not settle the continuing moral dispute about treating foreign patients with criminal records while Americans also needed organs.

A separate question concerned money. Federal law enforcement sources told the narrator that, in an international context, money laundering could mean moving criminal proceeds from overseas into the United States. Because organized-crime groups generally obtained much of their income through criminal activity, the sources suggested that at least some money paid to UCLA by one or more of the four patients could have originated in illegal activity in Japan. The narrator knew of no investigation into the men for money laundering, and any such inquiry would require cooperation from Japanese authorities. Whether UCLA knew of the patients’ ties or the possible source of their payments remained unanswered; the report raised that possibility without presenting it as a proven finding.

Public impact and limits

The report made Goto’s transplant and the possible intelligence bargain discussable beyond the circle that had known of the arrangement. Japanese press coverage frequently passed the story along under the Los Angeles Times’ name, but the narrator saw little evidence of reporters attempting independent confirmation or digging further. Attribution amplified the disclosure while also exposing the limits of the response: the initial revelation did not by itself establish what UCLA knew, prove that transplant rules had been violated, or trigger a known money-laundering investigation.

The episode’s force lies in the questions it leaves in tension. Goto faced a potentially fatal medical condition and obtained a transplant after securing a U.S. visa; the FBI sought information it could not get through official Japanese channels; and patients competed for organs in a system defined by scarcity. The Los Angeles Times report brought these strands into public view, but the available account distinguishes clearly between what was documented, what investigators suspected, and what remained unknown.

Related StoryFlow